References

  1. Noizat-Pirenne F et al. Molecular analysis of selected Rh variants. Transfus Clin Biol, 1996. [Citation] [RHeference]
  2. Noizat-Pirenne F et al. DAL: a new partial RHD phenotype. Transfusion, 2001. [Citation] [RHeference]
  3. Noizat-Pirenne F et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood, 2002. [Citation] [RHeference]
  4. Noizat-Pirenne F et al. Serological studies of monoclonal RH antibodies with RH1 (D), RH2 (C), RH3 (E) and RH5 (e) variant RBCs. Transfus Clin Biol, 2003. [Citation] [RHeference]
  5. Ansart-Pirenne H et al. RhD variants in Caucasians: consequences for checking clinically relevant alleles. Transfusion, 2004. [Citation] [RHeference]
  6. Noizat-Pirenne F et al. Weak D phenotypes and transfusion safety: where do we stand in daily practice? Transfusion, 2007. [Citation] [RHeference]
  7. Noizat-Pirenne F et al. Relevance of RH variants in transfusion of sickle cell patients. Transfus Clin Biol, 2011. [Citation] [RHeference]
  8. Bruno Costes et al. c.1154-31C>T Is in Linkage Disequilibrium with the Missense Mutation C.1154G>C on RHD Weak Type 2 Transfusion, 2017. — Abstract — [RHeference]
  9. Floch A et al. Molecular characterization of 13 new RHD alleles. Transfusion, 2017. [Citation] [RHeference]
  10. de Brevern AG et al. Alloimmunization risk associated with amino acid 223 substitution in the RhD protein: analysis in the light of molecular modeling. Transfusion, 2018. [Citation] [RHeference]
  11. Flegel WA et al. A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes. Blood Transfus, 2019. [Citation] [RHeference]
  12. Floch A et al. Comment from Rheference Online ressource, 2020. — Online ressource — [RHeference]
  13. Aline Floch et al. Understanding anti-D formation in RhD variants through the study of 3D intraprotein interactions manuscript in preparation, 2020. — Article — [RHeference]